Positive phase I trial for Schering-Plough HCV treatment
16th Nov 2005, 07:06 GMT
Schering-Plough's investigational oral hepatitis C protease inhibitor capsule, SCH 503034, demonstrated potent antiviral activity and was well-tolerated in a phase I trial of the drug in patients with hepatitis C virus genotype 1 who had not responded to previous therapy for their condition.
Positive phase I trial for Schering-Plough HCV treatment related news:
- Schering-Plough Posts Golimumab Data — Operations-Related News from StratCenter.com
- Merck/Schering-Plough Announces Update for the IMPROVE-IT Trial — Pharmaceuticals News from StratCenter.com
- Schering-Plough Licenses Technology — StratWire - Business of Healthcare NewsFeed
- Schering-Plough and Oncomethylome collaborate against brain cancer — Pharmaceutical Business Review Online
- Centocor: Centocor and Schering-Plough Next-Generation Biologic Shows Promise in the Treatment of Rheumatoid Arthritis in Phase 2 Trial — Market Wire - Pharmaceuticals and Biotech
- Centocor & Schering-Plough next generation biologic promising in phase 2 rheumatoid arthritis trial — EurekAlert! - Technology, Engineering and Computer Science
- Centocor and Schering-Plough drug shows promise in RA — Pharmaceutical Business Review Online
- Schering-Plough to Webcast Presentation at Credit Suisse 1st Boston Annual Health Care Conference — Operations-Related News from StratCenter.com
- Positive data from Oxxon hepatitis B trial — Pharmaceutical Business Review Online
- Advancis initiates phase III trial for sore throat treatment — Pharmaceutical Business Review Online
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol